These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Microautoradiographic analysis of the normal organ distribution of radioiodinated single-chain Fv and other immunoglobulin forms. Yokota T, Milenic DE, Whitlow M, Wood JF, Hubert SL, Schlom J. Cancer Res; 1993 Aug 15; 53(16):3776-83. PubMed ID: 8339291 [Abstract] [Full Text] [Related]
3. Targeting of bivalent anti-ErbB2 diabody antibody fragments to tumor cells is independent of the intrinsic antibody affinity. Nielsen UB, Adams GP, Weiner LM, Marks JD. Cancer Res; 2000 Nov 15; 60(22):6434-40. PubMed ID: 11103810 [Abstract] [Full Text] [Related]
4. Humanization of a highly stable single-chain antibody by structure-based antigen-binding site grafting. Villani ME, Morea V, Consalvi V, Chiaraluce R, Desiderio A, Benvenuto E, Donini M. Mol Immunol; 2008 May 15; 45(9):2474-85. PubMed ID: 18313757 [Abstract] [Full Text] [Related]
5. Making cell-permeable antibodies (Transbody) through fusion of protein transduction domains (PTD) with single chain variable fragment (scFv) antibodies: potential advantages over antibodies expressed within the intracellular environment (Intrabody). Heng BC, Cao T. Med Hypotheses; 2005 May 15; 64(6):1105-8. PubMed ID: 15823695 [Abstract] [Full Text] [Related]
17. In vivo targeting of malignant melanoma by 125Iodine- and 99mTechnetium-labeled single-chain Fv fragments against high molecular weight melanoma-associated antigen. Kang N, Hamilton S, Odili J, Wilson G, Kupsch J. Clin Cancer Res; 2000 Dec 22; 6(12):4921-31. PubMed ID: 11156253 [Abstract] [Full Text] [Related]
18. Development and characterization of three recombinant single chain antibody fragments (scFvs) directed against the CD19 antigen. Bejcek BE, Wang D, Berven E, Pennell CA, Peiper SC, Poppema S, Uckun FM, Kersey JH. Cancer Res; 1995 Jun 01; 55(11):2346-51. PubMed ID: 7538901 [Abstract] [Full Text] [Related]